Insulet
PODD
#1051
Rank
C$25.69 B
Marketcap
$366.25
Share price
-0.40%
Change (1 day)
52.39%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): C$0.41 Billion

According to Insulet's latest financial reports the company's current earnings are C$1.87 Billion. In 2023 the company made an earning of C$0.35 Billion, an increase over its 2022 earnings that were of C$60.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.41 B16.91%
2023 C$0.35 B481.9%
2022 C$60.68 M-45.24%
2021 C$0.11 B43.35%
2020 C$77.29 M18.51%
2019 C$65.22 M41.16%
2018 C$46.2 M-711.95%
2017 -C$7.56 Million-56.85%
2016 -C$17.51 Million-79.31%
2015 -C$84.61 Million63.85%
2014 -C$51.64 Million31.04%
2013 -C$39.41 Million-21.96%
2012 -C$50.5 Million
2010 -C$48.16 Million-42.38%
2009 -C$83.58 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$75.82 Million209.75%
2006 -C$24.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$10.34 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.2 Billion-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.07 B 149.07%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.90 B 5,905.55%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.54 B 2,112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.94 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$14.29 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA